Showing results (111-120 of 2,829) with videos related to
Sort By:
Pageof 283
Nanomedicine (London, England)|October 1, 2015
Use of ultrasmall superparamagnetic iron oxide particles for imaging carotid atherosclerosisAmmara Usman, Umar Sadat, Andrew J Patterson, et al.Nanomedicine (London, England)|January 20, 2016
Nanocomplexes from RGD-modified generation 1.0 polyamidoamine based copolymers used for intravascular gene release to prevent restenosisDuanwen Cao, Shouqin Tian, Wu Yi, et al.Nanomedicine (London, England)|January 20, 2016
Mesoporous silica nanoparticles in tissue engineering--a perspectiveJessica Maria Rosenholm, Jixi Zhang, Mika Linden, et al.Nanomedicine (London, England)|January 21, 2016
Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER(-)/PR(-)/HER2(-))Jagat R Kanwar, Sishir K Kamalapuram, Subramanian Krishnakumar, et al.Nanomedicine (London, England)|January 21, 2016
Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritanceJacqueline A Tickle, Stuart I Jenkins, Boris Polyak, et al.Nanomedicine (London, England)|January 21, 2016
Interactions between DNA and Gemini surfactant: impact on gene therapy: part ITaksim Ahmed, Amany O Kamel, Shawn D WettigNanomedicine (London, England)|January 21, 2016
Efficacy of DOPE/DC-cholesterol liposomes and GCPQ micelles as AZD6244 nanocarriers in a 3D colorectal cancer in vitro modelVíctor López-Dávila, Tarig Magdeldin, Hazel Welch, et al.Nanomedicine (London, England)|January 21, 2016
Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapyAarohi Bhargava-Shah, Kira Foygel, Rammohan Devulapally, et al.Nanomedicine (London, England)|February 2, 2016
An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicityLouis T Curtis, Christopher G England, Min Wu, et al.Nanomedicine (London, England)|November 22, 2014
Nanomedicine strategies for hematological malignancies: what is next?Giuseppe Visani, Federica Loscocco, Alessandro IsidoriPageof 283